Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

The TEAS score tends to carry more weight in a nursing application than people expect, and a surprising amount of prep material still teaches the retired TEAS 6 framework. Checking the version is the first thing to do before committing a month of study to anything. The exam covers four subjects, most students are weak […]

The post Best TEAS test preparation materials for nursing school applicants appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

If you find yourself telling a patient ‘It’s normal’ during a consultation, you might want to revisit that conversation. Academics from the Rady School of Management, UCSD reported this week that well-meaning reassurance by doctors can backfire. PhD student Seyi Lawal describes in a research article published in Nature Human Behaviour, how she found that […]

The post Doctors, Stop Telling Your Patients, ‘It’s Normal’ appeared first on Medical News Bulletin.

Scenario 1: Your patient is an executive at large company and experiences anxiety before the weekly board meeting. She wishes there were a simple strategy to help her cope.
Scenario 2: Your patient is a medical student and experiences stress from his workload. He needs a technique he could use before exams and to manage stress during the day.
Diaphragmatic may be a useful tool to manage stress and anxiety.
Persistent and unmanaged psychological stress may exacerbate many medical conditions and lead to pain, difficulty sleeping, fatigue, anxiety and depression. WHO states that every individual

DENVER — A gene therapy showed “encouraging visual function improvements” in patients with Usher syndrome type 1B, according to a phase 1/2 trial presented at the Association for Research in Vision and Ophthalmology meeting.
“Usher 1 syndrome is a disease in which children are born profoundly deaf,” Jayashree Sahni, MD, FRCOphth, PhD, EMBA, told Healio. “Over their lifetime, they start developing vestibular imbalance, and then slowly they have night blindness and progressive loss of vision.”
Participants received a low, medium or high dose of AAVB-081 (AAVantgarde Bio). The primary endpoint was

Reminders sent to primary care physicians and patients to schedule and conduct lung cancer screening improved adherence, according to the results of a clinical trial.
Data published last year by the American Lung Association show that the 5-year lung cancer survival rate rose more than 25% over the last decade due to increased lung cancer screening, although national screening rates are still below 20%.
“Multilevel barriers at the patient, clinician, and system levels contribute to low adherence rates,” Karen J. Wernli, PhD, a cancer epidemiologist at Kaiser Permanente Washington

An electronic health record nudge-based intervention led to a significant increase in molecular testing among patients with early-stage non-small cell lung cancer.
The trial provided “proof of concept” for the strategy, which could be applied in the neoadjuvant setting for nonsquamous NSCLC, and broadly within cancer care, both at large centers and in the community setting.
“If you make something the easiest default option within an electronic medical record system, it can lead to guideline-concordant change,” Melina E. Marmarelis, MD, MSCE, associate professor of medicine at University of

Editor’s note: This is a developing news story. Please check back soon for updates.
Oculis will acquire all worldwide development and commercial rights to privosegtor, Accure Therapeutics’ lead candidate for optic neuritis, according to a press release.
The transaction will include a $3.8 million up-front cash payment from Oculis, with up to 2,050,000 shares to be issued to Accure for the complete acquisition of both privosegtor, also known as ACT-01, and ACT-02, a preclinical neurology drug candidate. Up-front shares will be subject to lockup release over a period of up to 2 years, and earnout

CMS has announced a final rule ending federal CHIP and Medicaid funds for gender-affirming care in youth.
The policy is scheduled to take effect on Oct. 13, but the funding “will be available for a tapering-off period of up to 6 months from the effective date of the final rule for children currently on hormone therapy,” according to a press release from CMS.
This does not impact mental health services, according to the release, as “Medicaid’s Early and Periodic Screening, Diagnostic, and Treatment provisions continue to ensure comprehensive coverage of mental health services for eligible

A joint statement issued by three organizations warned healthcare professionals about potential safety risks for patients receiving a newly approved therapy to treat Prader-Willi syndrome.
Prader-Willi Syndrome Association USA, the Foundation for Prader-Willi Research and the International Prader-Willi Syndrome Organization released a statement to raise awareness about reports of serious adverse events among patients with Prader-Willi syndrome using diazoxide choline extended-release (Vykat XR, Neurocrine Biosciences). As Healio previously reported, diazoxide choline extended-release was

People with HIV who switched from daily medication to an investigational once-weekly pill containing islatravir and lenacapavir remained virally suppressed on the new combination, according to the results of two phase 3 trials.
The findings, presented recently at the International AIDS Conference in Rio de Janeiro and published in The New England Journal of Medicine, were “highly anticipated,” International AIDS Society president Kenneth Ngure, PhD, MPH, told reporters.
Choice has become a vital component in modern HIV care, and the advent of long-acting drugs has given people with